Navigation Links
Canola Oil Can Help Americans Meet Dietary Fat Recommendations
Date:10/4/2007

WASHINGTON, Oct. 4 /PRNewswire-USNewswire/ -- Substitution of canola oil for common dietary fats in the U.S. would increase compliance with recommended intakes of saturated, monounsaturated and plant omega-3 fats, noted a modeling study published in the October 2007 issue of the Journal of the American Dietetic Association (JADA). The study examined the effect of substituting canola oil for selected vegetable oils and canola oil-based margarine for other margarines and butter in the diet of nearly 9,000 adult Americans.

"The results of this study show that fatty acid intake can be influenced substantially through a simple recommendation to change the type of vegetable oil used at the table and in cooking," wrote co-authors Guy H. Johnson, Ph.D., president, Johnson Nutrition Solutions LLC; Debra Keast, Ph.D., principal, DR Keast Food and Nutrition Database Research Consulting; and Penny Kris-Etherton, Ph.D., R.D., distinguished professor of nutrition, The Pennsylvania State University. "The lack of consumer barriers to such a change with respect to cost, taste, convenience and availability makes canola oil attractive from a practical perspective."

Food recall data from the 1999-2002 National Health and Nutrition Examination Survey were used to calculate the effect of substituting canola oil for corn, cottonseed, safflower, soybean and vegetable oils "not further specified" (excluding olive oil) and of canola oil-based margarine for other margarines and butter in the diet at 25%, 50% and 100% replacement levels. Results showed that saturated fat intake would decrease by 4.7% and 9.4% with 50% and 100% substitution, respectively. Complete substitution would increase monounsaturated fat and alpha-linolenic acid (ALA, an omega-3 fatty acid) intakes by 27.6% and 73.0%, respectively.

"The findings are provocative because they suggest that fairly simple recipe modifications and product reformulations could substantially increase the percentage of th
'/>"/>

SOURCE U.S. Canola Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Poll Finds Many Americans Misinformed About Cancer
2. Poll Finds Many Americans Misinformed About Cancer
3. Hypertension Drug of Choice for African Americans
4. 38 million Americans including 14 million children left to combat hunger
5. Americans Consume Far Too Much Salt and Sodium
6. Americans Growing Out Of Shape
7. Rise in Stress among Americans
8. Home Remedies More Used By Blacks And Native Americans
9. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
10. Aspirin, Not Used By African Americans And Diabetics To Prevent Heat Problems
11. Americans Not Interested In Choosing Sex Of Child: Survey
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:More women with early-stage breast cancer choosing double mastectomies 2Health News:HealthMapRx, Mirixa and the City of Asheville Announce New Partnership to Improve Health & Healthcare Savings of Beneficiaries With Chronic Diseases 2Health News:HealthMapRx, Mirixa and the City of Asheville Announce New Partnership to Improve Health & Healthcare Savings of Beneficiaries With Chronic Diseases 3Health News:Nuvilex, Inc. Announces Investor Conference Call and Open House 2Health News:Nuvilex, Inc. Announces Investor Conference Call and Open House 3Health News:Children's Home + Aid Faces Revenue Shortfall 2Health News:Lifeclinic Names New Executive Vice President as its Presence in Non-Retail Wellness Sector Grows 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 3Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 4Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 5
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 1The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 2The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 3The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 4Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 1Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 1Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 3
Other Medicine Technology:Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 2Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 3Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 4Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10